Literature DB >> 21963282

Oh the irony: Iron as a cancer cause or cure?

Susan P Foy1, Vinod Labhasetwar.   

Abstract

Iron-oxide nanoparticles facilitate cancer diagnosis through enhanced contrast, selectively enhance tumor cell death with magnetic hyperthermia, and improve drug delivery with magnetic drug targeting. One application that remains largely unexplored is using the iron-oxide nanoparticles themselves to selectively inhibit tumor growth. In this leading opinion paper, we propose that high doses of iron-oxide nanoparticles can be used as a treatment for cancer by generating an oxidative assault against cancer. This proposal may be met with resistance considering the controversy surrounding iron in the field of cancer. Iron generates reactive oxygen species through the Fenton reaction, which may both cause - or cure cancer. Additionally, high demand for iron by cancer cells leads to contradictory therapeutic approaches: iron deprivation or overdose are both potential cancer therapies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963282      PMCID: PMC3193037          DOI: 10.1016/j.biomaterials.2011.09.047

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  35 in total

1.  Massive and prolonged administration of iron-dextran complex.

Authors:  L V FOYE; T V FEICHTMEIR
Journal:  N Engl J Med       Date:  1961-04-27       Impact factor: 91.245

2.  Induction of sarcoma in the rat by iron-dextran complex.

Authors:  H G RICHMOND
Journal:  Br Med J       Date:  1959-04-11

3.  EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Authors:  Costas G Hadjipanayis; Revaz Machaidze; Milota Kaluzova; Liya Wang; Albert J Schuette; Hongwei Chen; Xinying Wu; Hui Mao
Journal:  Cancer Res       Date:  2010-07-20       Impact factor: 12.701

4.  Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

Authors:  G Thomas Budd; Massimo Cristofanilli; Mathew J Ellis; Allison Stopeck; Ernest Borden; M Craig Miller; Jeri Matera; Madeline Repollet; Gerald V Doyle; Leon W M M Terstappen; Daniel F Hayes
Journal:  Clin Cancer Res       Date:  2006-11-01       Impact factor: 12.531

5.  Uptake of anti-anemic substance ferric-sorbitol-citrate by normal and malignant cells and its effects on expression of transferrin receptor 1 and ferritin.

Authors:  Maja Prutki; Marija Poljak-Blazi; Branka Mihaljevic; Visnja Orescanin; Neven Zarkovic
Journal:  Cancer Biother Radiopharm       Date:  2006-12       Impact factor: 3.099

6.  Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer.

Authors:  Jaemoon Yang; Choong-Hwan Lee; Hyun-Ju Ko; Jin-Suck Suh; Ho-Geun Yoon; Kwangyeol Lee; Yong-Min Huh; Seungjoo Haam
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

7.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

Authors:  A S Lübbe; C Bergemann; H Riess; F Schriever; P Reichardt; K Possinger; M Matthias; B Dörken; F Herrmann; R Gürtler; P Hohenberger; N Haas; R Sohr; B Sander; A J Lemke; D Ohlendorf; W Huhnt; D Huhn
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

8.  Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver.

Authors:  Alain Luciani; Claire Wilhelm; Patrick Bruneval; Patrick Cunin; Gwennhael Autret; Alain Rahmouni; Olivier Clément; Florence Gazeau
Journal:  Eur Radiol       Date:  2009-01-10       Impact factor: 5.315

9.  Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.

Authors:  Michael K Kiessling; Claus D Klemke; Marcin M Kaminski; Ioanna E Galani; Peter H Krammer; Karsten Gülow
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701

10.  Dietary intake and serum levels of iron in relation to oxidative stress in breast cancer patients.

Authors:  Yun-Jung Bae; Jee-Young Yeon; Chung-Ja Sung; Hyun-Sook Kim; Mi-Kyung Sung
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more
  11 in total

1.  Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy.

Authors:  Yanlan Liu; Xiaoyuan Ji; Winnie W L Tong; Diana Askhatova; Tingyuan Yang; Hongwei Cheng; Yuzhuo Wang; Jinjun Shi
Journal:  Angew Chem Int Ed Engl       Date:  2018-01-16       Impact factor: 15.336

2.  Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues.

Authors:  Saeid Zanganeh; Gregor Hutter; Ryan Spitler; Olga Lenkov; Morteza Mahmoudi; Aubie Shaw; Jukka Sakari Pajarinen; Hossein Nejadnik; Stuart Goodman; Michael Moseley; Lisa Marie Coussens; Heike Elisabeth Daldrup-Link
Journal:  Nat Nanotechnol       Date:  2016-09-26       Impact factor: 39.213

Review 3.  The role of iron homeostasis and iron-mediated ROS in cancer.

Authors:  Jia-Fu Ying; Ze-Bei Lu; Luo-Qin Fu; Yu Tong; Zhen Wang; Wei-Fen Li; Xiao-Zhou Mou
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

Review 4.  The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer.

Authors:  Angela DeRosa; Avigdor Leftin
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

5.  Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.

Authors:  Mariana Campos da Paz; Maria de Fátima M Almeida Santos; Camila M B Santos; Sebastião W da Silva; Lincoln Bernardo de Souza; Emília C D Lima; Renata C Silva; Carolina M Lucci; Paulo César Morais; Ricardo B Azevedo; Zulmira G M Lacava
Journal:  Int J Nanomedicine       Date:  2012-10-04

6.  Effect of magnetic nanoparticles on apoptosis and cell cycle induced by wogonin in Raji cells.

Authors:  Lei Wang; Haijun Zhang; Baoan Chen; Guohua Xia; Shuai Wang; Jian Cheng; Zeye Shao; Chong Gao; Wen Bao; Liang Tian; Yanyan Ren; Peipei Xu; Xiaohui Cai; Ran Liu; Xuemei Wang
Journal:  Int J Nanomedicine       Date:  2012-02-14

7.  Nanoparticle-based hyperthermia distinctly impacts production of ROS, expression of Ki-67, TOP2A, and TPX2, and induction of apoptosis in pancreatic cancer.

Authors:  Robert Ludwig; Francisco J Teran; Ulf Teichgraeber; Ingrid Hilger
Journal:  Int J Nanomedicine       Date:  2017-02-07

8.  Antioxidant as an anticancer: consideration.

Authors:  Viroj Wiwanitkit; Kamon Chaiyasit
Journal:  Daru       Date:  2012-12-19       Impact factor: 3.117

9.  Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.

Authors:  Ganna Chornokur; Hui-Yi Lin; Jonathan P Tyrer; Kate Lawrenson; Joe Dennis; Ernest K Amankwah; Xiaotao Qu; Ya-Yu Tsai; Heather S L Jim; Zhihua Chen; Ann Y Chen; Jennifer Permuth-Wey; Katja K H Aben; Hoda Anton-Culver; Natalia Antonenkova; Fiona Bruinsma; Elisa V Bandera; Yukie T Bean; Matthias W Beckmann; Maria Bisogna; Line Bjorge; Natalia Bogdanova; Louise A Brinton; Angela Brooks-Wilson; Clareann H Bunker; Ralf Butzow; Ian G Campbell; Karen Carty; Jenny Chang-Claude; Linda S Cook; Daniel W Cramer; Julie M Cunningham; Cezary Cybulski; Agnieszka Dansonka-Mieszkowska; Andreas du Bois; Evelyn Despierre; Ed Dicks; Jennifer A Doherty; Thilo Dörk; Matthias Dürst; Douglas F Easton; Diana M Eccles; Robert P Edwards; Arif B Ekici; Peter A Fasching; Brooke L Fridley; Yu-Tang Gao; Aleksandra Gentry-Maharaj; Graham G Giles; Rosalind Glasspool; Marc T Goodman; Jacek Gronwald; Patricia Harrington; Philipp Harter; Alexander Hein; Florian Heitz; Michelle A T Hildebrandt; Peter Hillemanns; Claus K Hogdall; Estrid Hogdall; Satoyo Hosono; Anna Jakubowska; Allan Jensen; Bu-Tian Ji; Beth Y Karlan; Linda E Kelemen; Mellissa Kellar; Lambertus A Kiemeney; Camilla Krakstad; Susanne K Kjaer; Jolanta Kupryjanczyk; Diether Lambrechts; Sandrina Lambrechts; Nhu D Le; Alice W Lee; Shashi Lele; Arto Leminen; Jenny Lester; Douglas A Levine; Dong Liang; Boon Kiong Lim; Jolanta Lissowska; Karen Lu; Jan Lubinski; Lene Lundvall; Leon F A G Massuger; Keitaro Matsuo; Valerie McGuire; John R McLaughlin; Iain McNeish; Usha Menon; Roger L Milne; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Heli Nevanlinna; Ursula Eilber; Kunle Odunsi; Sara H Olson; Irene Orlow; Sandra Orsulic; Rachel Palmieri Weber; James Paul; Celeste L Pearce; Tanja Pejovic; Liisa M Pelttari; Malcolm C Pike; Elizabeth M Poole; Harvey A Risch; Barry Rosen; Mary Anne Rossing; Joseph H Rothstein; Anja Rudolph; Ingo B Runnebaum; Iwona K Rzepecka; Helga B Salvesen; Eva Schernhammer; Ira Schwaab; Xiao-Ou Shu; Yurii B Shvetsov; Nadeem Siddiqui; Weiva Sieh; Honglin Song; Melissa C Southey; Beata Spiewankiewicz; Lara Sucheston; Soo-Hwang Teo; Kathryn L Terry; Pamela J Thompson; Lotte Thomsen; Ingvild L Tangen; Shelley S Tworoger; Anne M van Altena; Robert A Vierkant; Ignace Vergote; Christine S Walsh; Shan Wang-Gohrke; Nicolas Wentzensen; Alice S Whittemore; Kristine G Wicklund; Lynne R Wilkens; Anna H Wu; Xifeng Wu; Yin-Ling Woo; Hannah Yang; Wei Zheng; Argyrios Ziogas; Hanis N Hasmad; Andrew Berchuck; Edwin S Iversen; Joellen M Schildkraut; Susan J Ramus; Ellen L Goode; Alvaro N A Monteiro; Simon A Gayther; Steven A Narod; Paul D P Pharoah; Thomas A Sellers; Catherine M Phelan
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

Review 10.  Oxidative DNA damage from nanoparticle exposure and its application to workers' health: a literature review.

Authors:  Kyung-Taek Rim; Se-Wook Song; Hyeon-Yeong Kim
Journal:  Saf Health Work       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.